State
73,734 recalls have nationwide distribution and so reach Nebraska. 4,580 additional recalls listed Nebraska specifically in their distribution scope.
Of the 4,580 recalls naming Nebraska we have scored against our rubric, 713 (16%) are Critical — deaths or serious injuries reported, or the agency’s own highest classification — and 1,345 (29%) are Severe.
Which agencies issued them
These figures cover only the 4,580 recalls whose distribution notice names Nebraska specifically. The 73,734 nationwide recalls listed below reach every state, so counting them here would make every state page show the same numbers.
Assurance Infusion is recalling specific lots of Sufentanil 150mcg/mL injection syringes due to a lack of sterility assurance.
Hikma Pharmaceuticals is recalling specific lots of Ketorolac Tromethamine Injection because of the presence of polydimethylsiloxane particles.
Assurance Infusion is recalling specific lots of Trimix Forte 4 injection because the product may lack sterility assurance.
Assurance Infusion is recalling BUP 35MG/FENT 1.5MG/ML in 20 mL syringes due to a lack of sterility assurance. The affected lot was distributed nationwide.
Assurance Infusion is recalling specific lots of Morphine 2mg/mL injection syringes due to a lack of sterility assurance.
Assurance Infusion is recalling a specific lot of buprenorphine and fentanyl injection due to a lack of sterility assurance. The product was distributed nationwide.
Assurance Infusion is recalling specific syringes of a multi-drug injection due to a lack of sterility assurance. The product was distributed nationwide.
Assurance Infusion is recalling QUADMIX FORTE in 1 mL vials because of a lack of sterility assurance. The recall covers 5 vials distributed nationwide.
Assurance Infusion is recalling specific lots of Morphine 5mg/mL injection syringes due to a lack of sterility assurance.
Assurance Infusion is recalling 45 vials of Trimix Super injection nationwide due to a lack of sterility assurance.
Assurance Infusion is recalling a specific lot of BUP 20MG/CLON 300MCG/FENT 2000MCG/ML Injection due to a lack of sterility assurance.
Assurance Infusion is recalling specific lots of Hydromorphone 6mg/mL injection due to a lack of sterility assurance.
Assurance Infusion is recalling specific syringes of a multi-drug injection due to a lack of sterility assurance. The product was distributed nationwide.
Assurance Infusion is recalling BUP 20MG/SUF 1000MCG/ML Injection syringes due to a lack of sterility assurance. The recall covers nationwide distribution in the United States.
Assurance Infusion is recalling specific lots of Buprenorphine and Fentanyl injection due to a lack of sterility assurance.
Assurance Infusion is recalling Morphine 15mg/mL injection syringes due to a lack of sterility assurance. The recall covers products distributed nationwide in the United States.
Assurance Infusion is recalling specific lots of a Clonazepam and Morphine injection because of a lack of sterility assurance. The product was distributed nationwide.
Assurance Infusion is recalling specific lots of Buprenorphine and Hydromorphone injection due to a lack of sterility assurance.
Assurance Infusion is recalling 19 vials of CJC-1295 and Ipamorelin injections nationwide due to a lack of sterility assurance.
Assurance Infusion is recalling specific lots of BUP 10MG/HYDROM 15MG/SUF 200MCG/ML Injection syringes due to a lack of sterility assurance.
Assurance Infusion is recalling a specific lot of multi-drug injection syringes due to a lack of sterility assurance. The product was distributed nationwide.
Assurance Infusion is recalling specific lots of Baclofen and Hydromorphone injection due to a lack of sterility assurance.
Assurance Infusion is recalling specific lots of Hydromorphone 2mg/mL injection syringes because of a lack of sterility assurance.
Assurance Infusion is recalling specific lots of Baclofen and Hydromorphone injection due to a lack of sterility assurance. The affected product was distributed nationwide.
Assurance Infusion is recalling BPC-157 vials nationwide because the product lacks sterility assurance.